Clinical Trials
5 trialsNCT05663866 2026-06-02
Premedication to Reduce Amivantamab Associated Infusion Related Reactions
Janssen Research & Development, LLC
Phase 2 Active not recruiting
NCT04487080 2026-05-08
MARIPOSA
Janssen Research & Development, LLC
Phase 3 Active not recruiting
NCT04538664 2026-05-08
PAPILLON
Janssen Research & Development, LLC
Phase 3 Active not recruiting
NCT04988295 2026-05-08
MARIPOSA-2
Janssen Research & Development, LLC
Phase 3 Active not recruiting
NCT05388669 2026-05-08
PALOMA-3
Janssen Research & Development, LLC
Phase 3 Active not recruiting